Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Apremilast 💬
(Otezla (TN), OTEZLA)		1件: Apremilast1件: Apremilast4件: PDE4,
PDE4,
PDE4,
PDE4 💬 		4件: Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬7件: 46, 50, 56, 97, 107, 162, 271 💬
2 Ciprofloxacin 💬
(Otiprio (TN))		1件: Ciprofloxacin2件: Ciprofloxacin; Ciprofloxacin hydrochloride--6件: 2, 46, 60, 96, 97, 299 💬
3 Ciprofloxacin hydrochloride 💬
(CIPROFLOXACIN OTIC, CIPROFLOXACIN OTIC SOLUTION, 0.2%)		1件: Ciprofloxacin2件: Ciprofloxacin; Ciprofloxacin hydrochloride--6件: 2, 46, 60, 96, 97, 299 💬
4 Fluocinolone acetonide 💬
(FLAC OTIC OIL)		1件: Fluocinolone acetonide1件: Fluocinolone acetonide1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 90 💬
5 Methotrexate 💬
(Otrexup (TN), OTREXUP)		1件: Methotrexate5件: Methotrexat; Methotrexate; Methotrexate sodium; Metotrexato; Méthotrexate2件: DHFR,
DHFR 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬37件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
6 Omeprazole magnesium 💬
(Prilosec OTC (TN))		1件: Omeprazole3件: Omeprazol; Omeprazole; Omeprazole magnesium2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬14件: 6, 13, 21, 46, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298 💬
7 Otelixizumab 💬
(Otelixizumab (USAN))		1件: Otelixizumab (Otelixizumab)1件: Otelixizumab3件: CD3D,
CD3E,
CD3G 💬 		11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 46 💬
8 Otilimab 💬
(Otilimab (USAN), Otilimab (genetical recombination) (JAN))		1件: Otilimab (Otilimab)1件: Otilimab1件: CSF2 💬 16件: Acute myeloid leukemia, Amoebiasis, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬1件: 46 💬
9 Pegtibatinase 💬1件: Pegtibatinase (OT-58)1件: Pegtibatinase1件: CBS 💬 3件: Cysteine and methionine metabolism, Glycine, serine and threonine metabolism, One carbon pool by folate 💬1件: 337 💬
10 Ustekinumab 💬
(Otulfi (TN), OTULFI)		1件: Ustekinumab1件: Ustekinumab3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬16件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬